新奥尔良消息:美国大规模的研究表明,在阻止晚期前列腺癌的发展中,亮脯二氨酸(leuprolide)疗法增添抗雄激素,其疗效优于单用亮脯二氨酸. 联合治疗缓解短暂的疾病加剧,并缓解亮脯二氨酸单一疗法中常见的加剧疼痛.但总的来看,联合疗法只能适度地延长生存时间。 David Crawford医师在此地召开的美国临床肿瘤学学会的会议上说;“目前单用亮脯 NEW ORLEANS: A large-scale study in the United States has shown that leuprolide supplements antiandrogens in preventing the development of advanced prostate cancer, and its efficacy is superior to that of leucine alone. The disease is exacerbated and alleviates the exacerbation of pain commonly seen in leukotris monotherapy. But overall, combination therapy can only moderately prolong survival. Dr David Crawford said at the conference of the American Society of Clinical Oncology held here;